Cat. No.: DIA-0243109
Product Information | |
---|---|
CAS No. | 2401892-86-0 |
Formula | C34H36ClFN6O4 |
Molecular Weight | 647.14 |
SMILES | C[C@]1(C2=C(C=C(C=C2)Cl)F)OC3=C(C4CCN(CC4)CC(N(C5=C6)CC7=CN=CN7CC)=NC5=CC=C6C([O-])=O)C=CC=C3O1.[NH4+] |
Target | GCGR |
Product Description | GLP-1 receptor agonist 8 is a potent agonist of GLP-1 R. GLP-1 receptor agonist 8 has the potential for the research of diabetes, obesity, and nonalcoholic fatty liver disease (NAFLD) (extracted from patent WO2019239319A1, compound 17). |
Format & Storage | |
---|---|
Shipping | Room temperature in the continental U.S. Other areas may vary. |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.